Skip to article
Astra

Emergency Medicine

Adult Diabetic Ketoacidosis

Adult diabetic ketoacidosis requires immediate recognition of insulin deficiency, volume depletion, electrolyte derangement, and its precipitant. This review focuses on rapid diagnostic confirmation, diabetes-type reassessment, safe insulin-dependent care, and prevention of recurrent hyperglycemic crises using currently supplied evidence.

Clinical question: How should clinicians recognize diabetic ketoacidosis, clarify diabetes type, and prevent recurrent hyperglycemic crises in adults?

Immediate assessment

Treat suspected DKA as an insulin-deficient emergency

DKA should trigger simultaneous stabilization, biochemical assessment, and cause-directed evaluation.

DKA reflects clinically consequential insulin deficiency with hyperglycemia, ketonemia, dehydration, acidemia, and electrolyte disturbance. It is classically associated with type 1 diabetes but can occur in insulinopenic type 2 diabetes, ketosis-prone type 2 diabetes, acute illness, missed insulin, and sodium-glucose cotransporter 2 inhibitor exposure. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

The supplied sources do not provide a complete adult DKA fluid, insulin infusion, potassium replacement, bicarbonate, or transition-to-subcutaneous-insulin protocol. Therefore, institutionally approved hyperglycemic-crisis pathways and current specialty guidance should govern acute resuscitation and monitoring rather than extrapolation from the diabetes-management sources reviewed here. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Clinical classification issues that change management after DKA resolution. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
FindingClinical implicationNext action
Classic hyperglycemic symptoms or hyperglycemic crisis with random plasma glucose ≥200 mg/dLDiabetes is established clinically. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Treat the crisis and determine whether the patient has absolute or relative insulin deficiency. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Adult with weight loss, ketoacidosis, marked hyperglycemia, younger age, or low BMIFeatures favor autoimmune type 1 diabetes but no single feature is definitive. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Order GAD antibody; if negative and suspicion remains, add IA-2 and/or ZnT8 antibodies where available. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Insulin-treated adult with persistent uncertainty about diabetes typeC-peptide may clarify endogenous insulin secretion. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Use a random C-peptide with concurrent glucose within 5 hours of eating; avoid testing within 2 weeks after a hyperglycemic emergency. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Obesity or metabolic syndrome with DKADoes not exclude type 1 diabetes; ketosis-prone type 2 diabetes is also possible. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Maintain insulin until classification and insulin requirement are clear. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Diagnostic reasoning

Reassess diabetes type after initial stabilization

Misclassification can produce unsafe insulin withdrawal or delayed insulin initiation.

Diabetes classification is often uncertain at presentation. Type 1 diabetes can occur at any age, obesity does not exclude autoimmune diabetes, and approximately 40% of adults with newly diagnosed type 1 diabetes may initially be misdiagnosed as having type 2 diabetes. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

The most useful clinical features favoring type 1 diabetes are age younger than 35 years, BMI below 25 kg/m2, unintentional weight loss, ketoacidosis, and plasma glucose above 360 mg/dL at presentation. Family history, ketosis without acidosis, osmotic symptoms, and coexisting autoimmune disease are weaker discriminators. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

For adults with overlapping phenotypic features, standardized islet autoantibody testing is recommended. GAD is the preferred first test; if negative, IA-2 and/or ZnT8 antibodies should be considered where available. A negative antibody test does not exclude type 1 diabetes. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Interpretation of C-peptide in insulin-treated adults with uncertain diabetes classification. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Result or circumstanceInterpretationAction
Random C-peptide ≥600 pmol/L (≥1.8 ng/mL)Substantial endogenous insulin secretion; testing circumstances are less consequential. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Assess for type 2 diabetes, monogenic diabetes, or other nonautoimmune diabetes while integrating phenotype and autoantibody results. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Random C-peptide <80 pmol/L (<0.24 ng/mL)Very low endogenous insulin secretion. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Treat as severe insulin deficiency; do not discontinue insulin. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
C-peptide 200–600 pmol/L (0.6–1.8 ng/mL)Usually consistent with type 1 diabetes or MODY, but may occur in insulin-treated type 2 diabetes. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Interpret with concurrent glucose, duration of diabetes, phenotype, and antibody testing. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...
Within 2 weeks of hyperglycemic emergencyResult may not be appropriate for classification. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...Defer C-peptide testing until recovery. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Inpatient safety

Protect against recurrent ketosis during transitions of care

Insulin omission is a preventable driver of recurrent DKA in insulin-deficient diabetes.

For people with type 1 diabetes, uninterrupted basal insulin is essential to prevent hyperglycemia and ketoacidosis during hospitalization, fasting, and procedures. This requirement should be explicit in admission orders, perioperative plans, and handoffs. PubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH

Inpatient self-management may be appropriate only for selected patients who can safely administer insulin, monitor glucose, count carbohydrates, and participate in decisions under supervision from clinicians knowledgeable in glycemic management. PubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH

Hyperglycemia with DKA can also arise in type 2 diabetes during severe illness, insulin omission, or exposure to drugs including SGLT2 inhibitors. Because SGLT2 inhibitors can be associated with DKA, review these agents during every DKA evaluation. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Prevention

Use follow-up to prevent the next hyperglycemic crisis

Recurrent DKA prevention depends on insulin access, skills, monitoring, and timely phenotype clarification.

Diabetes self-management education and support is a core element of diabetes care. CDC guidance emphasizes ongoing team-based support and notes that structured diabetes self-management education and support is associated with lower A1C and fewer complications. CDCClinical Guidance for Diabetes

A1C monitoring frequency should reflect stability of therapy and glycemic control. CDC advises testing every 3 months when treatment has changed or goals are not met and every 6 months when treatment and glycemic goals are stable. CDCYour Diabetes Care Schedule

For type 2 diabetes treated with metformin plus an SGLT2 inhibitor or GLP-1 agonist, ACP states that routine self-monitoring of blood glucose may be unnecessary in stable patients; this does not apply to insulin-dependent patients or those at risk for hypoglycemia or recurrent ketosis. PubMedNewer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians

Evidence limitation

What the supplied evidence does not support

Avoid false precision when source material does not contain acute-care protocol details.

The provided search results include current diabetes diagnostic and classification guidance, longitudinal type 1 diabetes management, and general diabetes-care resources, but do not include a dedicated adult DKA consensus guideline or FDA labeling for insulin and adjunctive agents. Accordingly, they do not support publishing exact intravenous fluid choice or rate, insulin infusion dose, potassium replacement thresholds, bicarbonate criteria, phosphate therapy, anion-gap transition criteria, or ICU disposition thresholds. PubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIHDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Acute DKA care should therefore follow a current, locally adopted adult hyperglycemic-crisis protocol with endocrine and critical-care consultation as appropriate. Diabetes classification and recurrent-crisis prevention should proceed in parallel with acute stabilization. PubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIHDiabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Common questions

Can an adult with obesity and DKA still have type 1 diabetes?

Yes. Obesity does not exclude type 1 diabetes. In adults with DKA or an overlapping phenotype, evaluate clinical features, islet autoantibodies, and—after recovery when appropriate—C-peptide before reducing or discontinuing insulin. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

When should C-peptide be measured after DKA?

Do not measure C-peptide within 2 weeks of a hyperglycemic emergency. In insulin-treated patients with uncertain diabetes type, a random sample with concurrent glucose within 5 hours of eating can help classify endogenous insulin secretion after recovery. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

Should basal insulin be held when an adult with type 1 diabetes is fasting or hospitalized?

No. Type 1 diabetes requires uninterrupted basal insulin to prevent hyperglycemia and ketoacidosis, including during hospitalization, fasting, and procedures. PubMedThe Management of Type 1 Diabetes - Endotext - NCBI - NIH

What diabetes medications should be reviewed in every DKA presentation?

Review all insulin access and adherence, recent glucocorticoids or second-generation antipsychotics, and SGLT2 inhibitor exposure. DKA can occur in insulinopenic type 2 diabetes and has been associated with SGLT2 inhibitor use. Diabetes Journals2. Diagnosis and Classification of Diabetes: Standards of Care ...

References

  1. Drug Dosing Recommendations for All Patients: A Roadmap ...ascpt.onlinelibrary.wiley.com · ascpt.onlinelibrary.wiley.com
  2. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicianspmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  3. Newer Pharmacologic Treatments in Adults With Type 2 Diabetes: A Clinical Guideline From the American College of Physicians - PubMedpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  4. Quality of Care in Adults With Diabetes - Diabetes in America - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  5. A review of the quality of current diabetes clinical practice guidelines - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  6. Recent Updates to Clinical Practice Guidelines for Diabetes ...pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  7. Introduction and Methodology: Standards of Care in Diabetes—2026 - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  8. Type 2 diabetes in adults: management - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY - PubMedpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov
  10. 6. Glycemic Goals and Hypoglycemia: Standards of Care in ...www.ccjm.org · www.ccjm.org
  11. 16. Diabetes Care in the Hospital: Standards of Care in ...www.ccjm.org · www.ccjm.org
  12. Diabetes - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  13. Your Diabetes Care Schedulewww.cdc.gov · www.cdc.gov
  14. The Management of Type 1 Diabetes - Endotext - NCBI - NIHwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  15. 2. Classification and Diagnosis of Diabetes: Standards of ...diabetesjournals.org · diabetesjournals.org
  16. Diagnosis and Classification of Diabetes Mellitusdiabetesjournals.org · diabetesjournals.org
  17. 2. Diagnosis and Classification of Diabetes: Standards of Care ...diabetesjournals.org · diabetesjournals.org
  18. 2. Classification and Diagnosis of Diabetesdiabetesjournals.org · diabetesjournals.org
  19. NCT00081328 | Treatment Options for Type 2 Diabetes in ...clinicaltrials.gov · clinicaltrials.gov
  20. Type 2 diabetes in adults: management | Guidancewww.nice.org.uk · www.nice.org.uk
  21. Overview | Type 1 diabetes in adults: diagnosis and management | Guidance | NICEwww.nice.org.uk · www.nice.org.uk
  22. Clinical Guidance for Diabeteswww.cdc.gov · www.cdc.gov
  23. Management of Diabeteswww.who.int · www.who.int
  24. Considerations for Blood Glucose Monitoring and Insulin Administration | Injection Safety | CDCwww.cdc.gov · www.cdc.gov